Patents by Inventor Margaret Jackson

Margaret Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230382901
    Abstract: Disclosed are heteroaryl amide inhibitors of CD38 and methods of making and using the same in disease and disorder treatment.
    Type: Application
    Filed: October 8, 2021
    Publication date: November 30, 2023
    Inventors: Robert A. VOLKMANN, Jotham W. COE, Eric VERDIN, Rosalba PERRONE, Margaret JACKSON, Frederick R. NELSON, Elena SILVA, Steve FELSTEAD
  • Patent number: 9370516
    Abstract: The present invention relates to methods of treating sleep disorders in patients comprising administration of a ghrelin receptor inverse agonist or antagonist. The invention also includes methods of treating sleep disorders comprising the administration of a pharmaceutical composition comprising a ghrelin receptor inverse agonist or antagonist and at least one pharmaceutically acceptable carrier, diluent, or excipient.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: June 21, 2016
    Assignee: Pfizer Inc.
    Inventors: William S. Denney, Margaret Jackson, Gabriele Sonnenberg
  • Publication number: 20150119381
    Abstract: The present invention relates to methods of treating sleep disorders in patients comprising administration of a ghrelin receptor inverse agonist or antagonist. The invention also includes methods of treating sleep disorders comprising the administration of a pharmaceutical composition comprising a ghrelin receptor inverse agonist or antagonist and at least one pharmaceutically acceptable carrier, diluent, or excipient.
    Type: Application
    Filed: May 21, 2013
    Publication date: April 30, 2015
    Applicant: Pfizer Inc.
    Inventors: William S. Denney, Margaret Jackson, Gabriele Sonnenberg